Ascendis Pharma A/S is a DK-based company operating in Biotechnology industry. Ascendis Pharma A/S is a Denmark‑based biopharmaceutical company operating within the life sciences and biotechnology sector. The firm scope of activity includes discovery, development, and commercialization of innovative therapies for rare diseases and serious chronic conditions with significant unmet medical needs where a clinically validated parent drug or pathway is suitable to company technologies. Ascendis Pharma A/S focuses on the endocrinology area and has a pipeline of three independent rare disease product candidates, such as Growth Hormone Deficiency (GHD), Hypoparathyroidism and Achondroplasia. The second therapeutic area is oncology, where the company focuses immunotherapy to targeted therapies.
Jan Mikkelsen 2007 'den beri şirketle birlikte olan Ascendis Pharma A/S 'in President 'ıdır.
ASND hissesinin fiyat performansı nasıl?
ASND 'in mevcut fiyatı $238.59 'dir, son işlem günde 0% azalmış etti.
Ascendis Pharma A/S için ana iş temaları veya sektörler nelerdir?
Ascendis Pharma A/S Biotechnology endüstrisine ait ve sektör Health Care 'dir
Ascendis Pharma A/S 'in piyasa değerlemesi nedir?
Ascendis Pharma A/S 'in mevcut piyasa değerlemesi $14.4B 'dir
Ascendis Pharma A/S al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 22 analist Ascendis Pharma A/S için analist derecelendirmeleri gerçekleştirdi, bunlar 10 güçlü al, 12 al, 1 tut, 0 sat ve 10 güçlü sat içermektedir